Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Asahi Kasei Corporation - SIC # 3430 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AHKSY
Over the counter
3430
www.asahi-kasei.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Asahi Kasei Corporation
Asahi Kasei, Circularise, and Furuya Metal Launch Demonstration Project for Precious Metal Traceability in Chlor-Alkali Electrolysis Electrodes
- Nov 12th, 2026 6:30 am
Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production
- Nov 4th, 2026 6:30 am
Asahi Kasei Therapeutics Announces Late-Breaking Oral and Poster Presentations at IDWeek 2026
- Oct 21st, 2026 6:30 am
Asahi Kasei Strengthens Carbon Footprint Transparency for Acrylonitrile Production with Independent Third-Party Verification
- Oct 20th, 2026 6:30 am
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
- Oct 12th, 2026 6:09 am
FDA approves Asahi Kasei’s Hovilpri for refractory HSV
- Oct 12th, 2026 5:04 am
Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults
- Oct 9th, 2026 4:41 pm
Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements
- Oct 9th, 2026 6:30 am
Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients
- Oct 8th, 2026 6:30 am
Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics
- Sep 29th, 2026 6:30 am
Asahi Kasei Corp's Dividend Analysis
- Sep 29th, 2026 5:18 am
Battery Separators Market Outlook 2026-2035 - Featuring Profiles of Asahi Kasei, Toray Industries, and SK IE Technology
- Sep 25th, 2026 2:43 am
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
- Sep 15th, 2026 6:30 am
Asahi Kasei Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design
- Sep 8th, 2026 6:30 am
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
- Aug 31st, 2026 6:00 am
Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy
- Aug 26th, 2026 6:30 am
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries
- Aug 20th, 2026 6:30 am
Asahi Kasei’s Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives
- Aug 19th, 2026 6:30 am
Scroll